Cargando…
Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance
Tryptophan catabolism by indoleamine 2,3-dioxygenase (IDO1) is a physiological immunoregulatory mechanism often hijacked by tumors. Our recent extensive study of IDO1 protein expression in human tissues showed expression in mature dendritic cells and in pulmonary and placental endothelial cells. IDO...
Autores principales: | Vigneron, Nathalie, van Baren, Nicolas, Van den Eynde, Benoît J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485782/ https://www.ncbi.nlm.nih.gov/pubmed/26155395 http://dx.doi.org/10.1080/2162402X.2014.1003012 |
Ejemplares similares
-
Tryptophan-Degrading Enzymes in Tumoral Immune Resistance
por: van Baren, Nicolas, et al.
Publicado: (2015) -
CD4 responses against IDO
por: Andersen, Mads Hald
Publicado: (2012) -
Multiverse of immune microenvironment in metastatic colorectal cancer
por: Van den Eynde, Marc, et al.
Publicado: (2020) -
Metastasis immune-based scores predict patient survival
por: Mlecnik, Bernhard, et al.
Publicado: (2020) -
Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients
por: Baldin, Pamela, et al.
Publicado: (2020)